Navigation Links
MarketsandMarkets Partners With Eyeforpharma For The Pharma Forecasting Excellence Europe 2010 Summit
Date:4/23/2010

LONDON, April 23, 2010 /PRNewswire/ --

- Managing uncertainty; A Migraine For Pharma Forecasters

Forecasting in pharmaceuticals has its up's and down's, with new markets and products proving more complex and requiring sophisticated approaches to forecast these areas.

Dealing with uncertainties is no easy task. With a number of risks to consider, pharmaceutical forecasting teams need to be able to recognise commercial uncertainties surrounding a given product, capture it and manage the associated risk.

"As recent times have demonstrated the future is uncertain, but we have to make decision now." Says Nich Guthrie, Head of Forecasting - Global Marketing, AstraZeneca. "How we handle uncertainty, and not be paralysed by it, is critical to making good investment decisions".

Adopting successful risk management strategies and scenario analysis techniques can turn information into something more meaningful when tackling this challenge. Guthrie will discuss his experience and ideas on this very topic at the Pharma Forecasting Excellence summit in Zurich.

With a view to bringing key topics and innovations in forecasting to the forefront, Pharma Forecasting Excellence Europe 2010, 8-9th June, Zurich, presents best practices from pioneers in the industry.

A particular highlight will be Christian Naumann, VP Global Commercial Operations at Bayer-Schering who will be discussing their forecasting process and how to maximize the value for a global business.

    To view the full discussion visit
http://www.eyeforpharma.com/forecastingeu

MarketsandMarkets offers a specialized patient based forecast solutions for pipeline drugs across a brand's lifecycle

Forecasting plays a significant role in the pharma industry. Forecasting helps a Pharma company with opportunity analysis, resource planning & allocation, investment planning, go-no-go strategy, launch and go to market strategy. An epidemiology matrix is the back-bone of a forecast model. It takes into account prevalence, diagnosis and treatment. Epidemiology captures the impact of disease and patient dynamics; however, it is important to factor in impact of market dynamics to accurately estimate products and market potential. Capturing the impact of all market events and calibrating the forecasted model with the actual market is the appropriate way to accuracy. Calibration with the actual market scenario at every stage of forecast, including peak patient share estimation, treated patient calculation, sales calculation, etc makes the forecast more realistic and accurate.

MarketsandMarkets' patient based forecast solutions have assisted many pharma companies in their forecasting processes for pipeline and in market drugs. M&M Pharma forecasting solution is designed for phase I, II and III drugs. Forecasting has a significant impact on pricing, product launch & life cycle management, market entry strategy, manufacturing planning, sales force, promotion and planning.

    For more information visit
http://www.marketsandmarkets.com/patient-based-forecasting.asp

Meet up with the MarketsandMarkets representatives at the conference to discuss your forecasting needs!

    Media contact : EyeforPharma       Contact : MarketsandMarkets
    Puja Pankhania                     Navrose Singh Sandhu
    VP Europe                          T: +1-888-989-8004
    T: +44-(0)-207-375-7563            E: Navrose@marketsandmarkets.com
    E: Puja@eyeforpharma.com


'/>"/>
SOURCE Markets and Markets
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MarketsandMarkets Partners With IIR USA for Their Event Advanced Biomarker Strategies in Oncology Drug Development
2. MarketsandMarkets Partners with the 9th Annual ePharma Summit to be Held on February 8 -10, 2010
3. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
4. MarketsandMarkets: Healthcare Information Technology Systems Market to be Worth $53.8 Billion by 2014
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s highly popular SearchLight ... online modeling resource for fluorescence microscopists and optical system designers, enabling The Right ... years spanning the globe, SearchLight has become a tremendously popular tool for the ...
(Date:4/27/2017)... Austin, TX (PRWEB) , ... April 27, 2017 ... ... released its all natural deodorant. On the heels of Thinksport’s award-winning sunscreen they’ve ... safe, non-toxic deodorant that actually works! , Countless deodorants flood the aisles that ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product ... oil many times purer and more potent than the market has seen before. Swissx ... Switzerland, as well as a patented chromatography process for extraction, to produce its CBD ...
(Date:4/26/2017)... ... 26, 2017 , ... Journal of Oral Implantology – Tooth loss ... overall dental health, including complications with speech, eating, and overcompensation of mouth due to ... lost teeth. As the number of tooth replacements increase, it is imperative to design ...
(Date:4/26/2017)... TX (PRWEB) , ... April 26, 2017 , ... ... confer the distinction of Customer Excellence upon National Registry of Emergency Medical ... “Customer Engagement drives Financial Performance,” said Dr. Jan G. West, Ph.D. , ...
Breaking Medicine News(10 mins):